Macro Finance
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
CNBC Business·November 6, 2026·1 min read
Moderna raised its 2026 revenue growth outlook to 15% to 25%, up from a previous forecast of up to 10%. The biotech company's CEO said newer vaccines are gaining traction, driving the improved expectations. The announcement signals confidence in its pipeline and market adoption.
Read at CNBC BusinessDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.